EBRCZ · EBR Systems, Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's cash, cash equivalents, and marketable securities as of June 30, 2026, and its expectation to generate operating losses and negative operating cash flows in the foreseeable future, as well as potential liquidity to become less than the $2.5 million required under its existing debt covenants during the next twelve months, there exists substantial doubt regarding the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 11, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| — | $1.62M | — | — | |
| — | — | $3.18M | $3.28M | |
| — | $1.13M | — | — | |
| — | $490K | — | — | |
| — | 30.3% | — | — | |
| $25.61M | $23.94M | $27.07M | $27.15M | |
| $33.07M | $22.64M | $11.25M | $7.4M | |
| $649K | $403K | $587K | $752.26K | |
| $58.68M | $46.58M | $38.32M | $34.55M | |
| -$57.74M | -$46.09M | -$38.32M | -$34.55M | |
| — | -2850.15% | — | — | |
| -$57.09M | -$45.68M | -$37.73M | -$33.8M | |
| $5.47M | $5.64M | $6.03M | $4.48M | |
| $2.16M | $2.71M | $3.18M | $3.28M | |
| -$3.02M | -$2.67M | -$2.48M | -$486.32K | |
| -$60.76M | -$48.76M | -$40.8M | -$35.04M | |
| — | $2000 | $2000 | $1625 | |
| -$60.76M | -$48.76M | -$40.8M | -$35.04M | |
| — | -3015.34% | — | — | |
| -$60.71M | -$48.69M | -$40.89M | -$34.87M | |
| USD/shares | -$0.27 | -$0.12 | -$0.13 | -$0.12 |
| USD/shares | -$0.27 | -$0.12 | -$0.13 | -$0.12 |
| shares | — | 417.33M | 325M | 288.88M |
| shares | — | 417.33M | 325M | 288.88M |
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 10,000 | 10-Q filed 2026-08-11 |
| Long-term debt, including current maturities | 2026-06-30 | USD 41,800,000 | 10-Q filed 2026-08-11 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Operating lease liabilities | 2026-06-30 | USD 18,472,000 | 10-Q filed 2026-08-11 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 70 similar-size Medical Devices companies (of 156 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 |
|---|---|
| United States | $1,593,000 |
| International | $24,000 |
By Product & Service (USD)
| Component | FY2025 |
|---|---|
| WiSE CRT System | $1,548,000 |
| Battery Replacements | $54,000 |
| Surgical Tool Kits | $15,000 |